hormone harmony glp 1 GLP-Harmony Companion+ GLP-1s and PMOS: PCOS, Insulin

You may not seek to have your out-of-pocket costs or the full retail price of the Sanofi Insulin count toward your deductible, true-out-of-pocket (TrOOP), maximum out-of-pocket (MOOP), or any other out-of-pocket caps associated with any insurance coverage

Compare Oral and Injectable Compounded GLP-1 Formulations Oral Dissolvable Daily Compounded GLP-1 Formulations Administration Protocol and Technique: Place single tablet under tongue (sublingual administration) without chewing or swallowing Allow complete dissolution typically requiring 30-60 seconds of sublingual contact Avoid eating, drinking, smoking, or placing anything else in mouth for 30 minutes before and 30 minutes after administration to maximize absorption Daily morning administration on consistent schedule for stable medication levels Gradual dose escalation following provider-prescribed titration protocol Advantages of Oral Dissolvable Compounded GLP-1 Medications: Completely needle-free alternative eliminating injection anxiety, needle phobia, and sharps disposal requirements Daily routine may feel more familiar and intuitive for individuals accustomed to taking daily oral medications No refrigeration requirements for storage in most formulations (verify specific product requirements) Simplified travel logistics without needles, syringes, sharps containers, or cold chain maintenance Discreet administration possible in various settings without privacy concerns about injections May appeal to individuals with bleeding disorders, skin conditions, or other factors making injections problematic Considerations and Potential Disadvantages: Daily administration requires consistent routine and habit formation (versus weekly injectable schedule) Sublingual absorption may vary between individuals based on saliva pH, mucosal integrity, sublingual blood flow, and administration technique Less extensive clinical trial data compared to injectable formulations (oral semaglutide FDA-approved as Rybelsus for diabetes but at different doses

71% stop taking GLP-1s by 12 months 6 74% report gastrointestinal symptoms 7 65% report NO increased exercise after starting medication 8 This is why the Noom GLP-1 Rx Program with Noom GLP-1 Companion exists

This means your blood pressure may improve as semaglutide begins working, potentially making your current antihypertensive dose too strong

April 1, 2024: Ozempic Manufacturer Novo Nordisk Sues Pharmacies for Knock-Offs Ozempic manufacturer Novo Nordisk continues to pursue lawsuits against pharmacies that sell compounded semaglutide

What specific qualifications should I look for in a GLP-1 prescriber